Antramycin
3-(4,6-dihydroxy-3-methyl-11-oxo-5,6,6a,7-tetrahydropyrrolo[2,1-c][1,4]benzodiazepin-8-yl)prop-2-enamide
Also Known As: Antramycin, ANTHRAMYCIN, 3-(4,6-dihydroxy-3-methyl-11-oxo-5,6,6a,7-tetrahydropyrrolo[2,1-c][1,4]benzodiazepin-8-yl)prop-2-enamide
| Molecular Formula | C16H17N3O4 |
|---|---|
| Molecular Weight | 315.12192 g/mol |
| LogP | 0.58 |
| Topological Polar Surface Area | 115.89 Ų |
| Hydrogen Bond Donors | 4 |
| Hydrogen Bond Acceptors | 5 |
| Rotatable Bonds | 2 |
| Exact Mass | 315.12192 |
| Heavy Atoms | 23 |
| Complexity | 753 |
Chemical Identifiers
| CAS Number | 4803-27-4 |
|---|---|
| SMILES | CC1=C(C2=C(C=C1)C(=O)N3C=C(CC3C(N2)O)C=CC(=O)N)O |
Product Overview
Antramycin (CAS 4803-27-4), with molecular formula C16H17N3O4 and molecular weight 315.12192 g/mol. IUPAC: 3-(4,6-dihydroxy-3-methyl-11-oxo-5,6,6a,7-tetrahydropyrrolo[2,1-c][1,4]benzodiazepin-8-yl)prop-2-enamide.
Frequently Asked Questions
📚 Academic Support
Scientific research papers and technical documentation supporting this product for informed procurement decisions.
Technical Blog Article
Multi-source research profile: chemical properties, regulatory status, and sourcing guide for Antramycin.
Browse Technical Blog →No research papers found for this product yet.
We continuously update our academic references. Check back soon!